SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001764013-20-000026
Filing Date
2020-08-27
Accepted
2020-08-27 16:36:55
Documents
3
Period of Report
2020-08-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_159856059458314.html 3  
1 FORM 3 wf-form3_159856059458314.xml 3 1711
2 POWER OF ATTORNEY MICHAEL J. ELLIOTT powerofattorney_michaelx.htm EX-24 5007
3 POWER OF ATTORNEY MICHAEL J. ELLIOTT powerofattorney_michaelx001.jpg GRAPHIC 199837
  Complete submission text file 0001764013-20-000026.txt   283503
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address
Elliott Michael James (Reporting) CIK: 0001822515 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38906 | Film No.: 201143322